title: Is an additional post-myocardial infarction beta-blocker trial required in the era of early revascularization?
authors.forename: Hans
authors.initials: H
authors.lastname: Mickley
authors.forename: Hans
authors.initials: H
authors.lastname: Eiskjaer
authors.forename: Hans Erik
authors.initials: HE
authors.lastname: Bøtker
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000319:Adrenergic beta-Antagonists